Simon C Pacey, MD
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Do Changes in ctDNA Predict Response for Patients With Oesophageal Cancer Receiving Durvalumab (NCT03653052) | Simon C Pacey, MD | 2018-10-30 |
Track Simon C Pacey, MD automatically
Every clearance here is in the API, with alerts when new ones post.